| NCT Number | NCT07364838 |
| Lead Sponsor | Daewon Pharmaceutical Co., Ltd. |
| Conditions | GERD (Gastroesophageal Reflux Disease) |
| Enrollment | 24 participants |
| Start Date | 2024-11-21 |
| Primary Completion | 2025-04-08 (estimated) |
| Study Completion | 2025-04-08 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-23 |